Clinical Trials
5 trialsNCT05495464 2026-05-20
A Pilot "Window-3" Study of Acalabrutinib Plus Rituximab Followed by Brexucabtagene Autoleucel Therapy in Patients With Previously Untreated High-risk Mantle Cell Lymphoma
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Active not recruiting
NCT03295240 2025-05-13
The Study of Bendamustine, Rituximab, Ibrutinib, and Venetoclax in Relapsed, Refractory Mantle Cell Lymphoma
Memorial Sloan Kettering Cancer Center
Phase EARLY_PHASE1 Completed
NCT02484053 2018-07-11
Rapid Infusion Rituximab, Hematologic, Oncologic, and Rheumatologic Disorders
Baylor College of Medicine
Phase EARLY_PHASE1 Completed
NCT01022021 2017-01-10
Peripheral Blood Stem Cell (PBSC) Mobilization in Patients With Relapsed Lymphoma Treated With Bendamustine
University of Kansas Medical Center
Phase EARLY_PHASE1 Completed
NCT00734773 2012-05-18
Pilot Study of MGd + High-dose MTX-Based Chemoimmunotherapy + RT for Newly Dx PCNSL
Northwestern University
Phase EARLY_PHASE1 Withdrawn